Sight sciences, inc.SGHT.US Overview
SGHT Overall Performance
SGHT AI Analysis & Strategy
SGHT Recent Performance
1.53%
Sight sciences, inc.
0.81%
Avg of Sector
-1.14%
S&P500
SGHT PowerScanner
SGHT Key Information
SGHT Valuation Metrics
SGHT Earnings Table
SGHT Profile
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.